Tudor Investment Corp ET AL raised its stake in Expensify, Inc. (NASDAQ:EXFY - Free Report) by 2,760.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 289,717 shares of the company's stock after acquiring an additional 279,588 shares during the period. Tudor Investment Corp ET AL owned 0.38% of Expensify worth $971,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also made changes to their positions in the company. Mariner LLC acquired a new position in Expensify in the fourth quarter valued at $34,000. Tower Research Capital LLC TRC lifted its holdings in shares of Expensify by 1,194.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,834 shares of the company's stock valued at $36,000 after buying an additional 9,997 shares during the period. SG Americas Securities LLC purchased a new position in Expensify in the fourth quarter worth $39,000. Alpine Global Management LLC acquired a new position in shares of Expensify during the 4th quarter worth $40,000. Finally, R Squared Ltd acquired a new stake in shares of Expensify in the fourth quarter valued at about $46,000. 68.42% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital lowered their target price on Expensify from $5.00 to $4.50 and set a "buy" rating on the stock in a report on Friday.
Get Our Latest Analysis on EXFY
Insiders Place Their Bets
In other news, CEO David Michael Barrett sold 39,399 shares of Expensify stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $2.75, for a total value of $108,347.25. Following the transaction, the chief executive officer now directly owns 1,634,345 shares in the company, valued at approximately $4,494,448.75. The trade was a 2.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Daniel Vidal sold 9,000 shares of the firm's stock in a transaction that occurred on Friday, March 28th. The stock was sold at an average price of $3.15, for a total value of $28,350.00. Following the completion of the sale, the director now owns 232,428 shares of the company's stock, valued at $732,148.20. This represents a 3.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 280,921 shares of company stock valued at $886,854 in the last three months. Insiders own 12.27% of the company's stock.
Expensify Stock Performance
Shares of Expensify stock traded down $0.10 during trading hours on Monday, reaching $2.29. The company's stock had a trading volume of 205,056 shares, compared to its average volume of 637,367. The company's 50 day simple moving average is $3.02 and its 200 day simple moving average is $3.19. The stock has a market cap of $183.66 million, a P/E ratio of -12.67 and a beta of 1.86. Expensify, Inc. has a one year low of $1.24 and a one year high of $4.13.
Expensify (NASDAQ:EXFY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.09). Expensify had a negative return on equity of 14.72% and a negative net margin of 11.81%.
Expensify announced that its Board of Directors has approved a share buyback program on Thursday, February 27th that permits the company to repurchase $50.00 million in shares. This repurchase authorization permits the company to repurchase up to 20.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's leadership believes its shares are undervalued.
Expensify Profile
(
Free Report)
Expensify, Inc provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel.
See Also

Before you consider Expensify, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Expensify wasn't on the list.
While Expensify currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.